Cellularsludge in hunger-regulating neurons linked to worsening diabetes and obesity

A recent study published in Nature has identified a mechanism through which inflammation in the hypothalamus promotes fibrotic changes in the perineuronal nets (PNNs), a specialised extracellular matrix (ECM) in the arcuate nucleus (ARC). These changes contribute to metabolic dysfunction, worsening conditions like obesity and diabetes.

Background

When blood glucose levels rise, insulin is released from pancreatic beta cells and signals the ARC to regulate hunger and metabolism. However, loss of insulin sensitivity leads to overeating and fat accumulation, contributing to obesity. The ECM, a network of proteins and sugars surrounding cells, plays a crucial role in this process. In people with obesity, the ECM undergoes fibrotic changes, particularly around Agouti-Related Protein (AgRP)-releasing neurons in the hypothalamus, disrupting insulin signalling and contributing to metabolic diseases.

Study Overview

In the study, researchers fed mice a regular or a high-fat, high-sugar (HFHS) diet to induce diabetes. They investigated whether neuroinflammation contributed to fibrotic buildup in the ECM by performing immunohistochemistry and stereotaxic injections. The team selectively disrupted insulin receptors in AgRP neurons to determine if ECM fibrosis impaired insulin function. They also used insulin tagged with fluorescein isothiocyanate (FITC) to track its signalling in hypothalamic neurons.

To assess the effects of inflammation, the team used adeno-associated viruses (AAVs) expressing receptors for pro-inflammatory TNF-α and anti-inflammatory TGF-β, alongside chondroitinase ABC (chABC), which breaks down fibrotic nets. Patch-clamp electrophysiology tested insulin interaction with PNNs in vitro, and fluorosamine, a drug inhibiting chondroitin sulphate synthesis, was administered to evaluate its therapeutic potential.

Key Findings

The study revealed that obese mice exhibited increased fibrotic PNNs around ARC neurons, disrupting insulin signalling and increasing AgRP neuron firing. Enzymatic breakdown of these PNNs restored insulin sensitivity, improved glucose metabolism, and reduced weight. The fibrosis altered gene expression for insulin receptors, exacerbating insulin resistance. While fibrotic nets impaired insulin activity, they did not affect leptin, the body weight-regulating hormone.

Additionally, obesity heightened levels of the inflammatory marker TNF-α while reducing the anti-inflammatory TGF-β, leading to increased fibrotic buildup. Reducing hypothalamic inflammation improved ECM function, and fluorosamine restored insulin sensitivity and improved metabolic outcomes in obese mice.

Conclusion

This study shows that hypothalamic ECM remodelling plays a significant role in metabolic diseases. Drugs targeting fibrotic PNNs and inflammation in the hypothalamus could improve insulin sensitivity and offer new treatments for obesity and diabetes by enhancing metabolic function.